These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5735393)

  • 1. Susceptibility of Actinomyces species to lincomycin and its 7-halogenated analogues.
    Lerner PI
    Antimicrob Agents Chemother (Bethesda); 1968; 8():461-4. PubMed ID: 5735393
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro sensitivity of Actinomyces israelii, Actinobacillus actinomycetem-comitans and Bacteroides melaninogenicus to cephalothin, cephaloridine, gentamicin, fusidic acid and lincomycin].
    Spieckermann C
    Int Z Klin Pharmakol Ther Toxikol; 1970 Oct; 4(4):318-20. PubMed ID: 5494880
    [No Abstract]   [Full Text] [Related]  

  • 3. [In vitro sensitivity of Actinomyces israelii, Actinobacillus actinomycetem-comitans and Bacteroides melaninogenicus to cephalothin, cephaloridine, gentamicin, fusidic acid and lincomycin].
    Spieckermann C
    Int Z Klin Pharmakol Ther Toxikol; 1970 Oct; 3(4):318-20. PubMed ID: 5481995
    [No Abstract]   [Full Text] [Related]  

  • 4. Actinomyces pyogenes: susceptibility of 103 clinical animal isolates to 22 antimicrobial agents.
    Guérin-Faublée V; Flandrois JP; Broye E; Tupin F; Richard Y
    Vet Res; 1993; 24(3):251-9. PubMed ID: 8343809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Actinomyces to cephalosporins and lincomycin.
    Lerner PI
    Antimicrob Agents Chemother (Bethesda); 1967; 7():730-5. PubMed ID: 5596213
    [No Abstract]   [Full Text] [Related]  

  • 6. Antimicrobial susceptibility testing of Actinomyces species with 12 antimicrobial agents.
    Smith AJ; Hall V; Thakker B; Gemmell CG
    J Antimicrob Chemother; 2005 Aug; 56(2):407-9. PubMed ID: 15972310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lincomycin plate inoculation modified for accurate interpretation.
    Vet Med Small Anim Clin; 1976 Sep; 71(9):1177. PubMed ID: 1049165
    [No Abstract]   [Full Text] [Related]  

  • 8. [In-vitro activity of clindamycin and lincomycin in the presence of Staphylococcus aureus].
    Wiedemann B
    Fortschr Med; 1984 Jun; 102(21):603-4. PubMed ID: 6469163
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antibacterial effect of lincomycin and 7-chloro-7-desoxylincomycin (Sobelin)].
    Ritzerfeld W; Nelke H
    Arch Hyg Bakteriol; 1970 Jun; 154(1):37-41. PubMed ID: 5475696
    [No Abstract]   [Full Text] [Related]  

  • 10. [Actinomyces as test organism in primary screening of new biologically active substances].
    Preobrazhenskaia TP; Ivanitskaia LP; Klitsunova NV; Manafova NA
    Antibiotiki; 1971 Nov; 16(11):963-5. PubMed ID: 5147755
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of lincomycin and other protein synthesis inhibitors on the metabolism of Actinomyces roseolus, a producer of lincomycin].
    Griaznova NS; Beliavskaia IV; Listvinova SN; Sazykin IuO; Orlova NV
    Antibiotiki; 1980 Apr; 25(4):250-6. PubMed ID: 7369728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible role of lincomycin-therapy in the genetic alteration of a staphylococcus epidemic population.
    Barcs I; Dobronyi I
    Acta Microbiol Hung; 1984; 31(3):173-8. PubMed ID: 6516785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of lincomycin on its own producer, Actinomyces roseolus, during prolonged passage on a liquid culture medium].
    Listvinova SN; Zaslavskaia PL; Dmitrieva SV; Orlova NV
    Antibiotiki; 1980 Feb; 25(2):88-92. PubMed ID: 7356310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lincomycin: activity in vitro and absorption and excretion in normal young men.
    McCall CE; Steigbigel NH; Finland M
    Am J Med Sci; 1967 Aug; 254(2):144-55. PubMed ID: 4951792
    [No Abstract]   [Full Text] [Related]  

  • 15. Susceptibility to selected antibiotics of Streptococcus pneumoniae and Streptococcus pyogenes strains isolated from patients with respiratory tract infections.
    Mazur E; Ligieza J; Niedźwiadek J; Polak G; Kozioł-Montewka M; Hencner Z
    Ann Univ Mariae Curie Sklodowska Med; 1999; 54():407-10. PubMed ID: 11205800
    [No Abstract]   [Full Text] [Related]  

  • 16. Susceptibilities of Actinomyces species and Propionibacterium propionicus to antimicrobial agents.
    Tanaka-Bandoh K; Watanabe K; Kato N; Ueno K
    Clin Infect Dis; 1997 Sep; 25 Suppl 2():S262-3. PubMed ID: 9310699
    [No Abstract]   [Full Text] [Related]  

  • 17. Susceptibility of bacterial pathogens against lincomycin/spectinomycin (1/2), penicillin G/neomycin (1/1), and penicillin G/dihydrostreptomycin (1/1) as determined in the BfT-GermVet monitoring program 2004-2006.
    Schwarz S; Werckenthin C; Alesík E; Wieler LH; Wallmann J
    Berl Munch Tierarztl Wochenschr; 2007; 120(9-10):363-71. PubMed ID: 17939451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity produced by six dentifrices.
    Settembrini L; Gultz J; Boylan R; Scherer W
    Gen Dent; 1998; 46(3):286-8. PubMed ID: 9693543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo comparisons of valnemulin, tiamulin, tylosin, enrofloxacin, and lincomycin/spectinomycin against Mycoplasma gallisepticum.
    Jordan FT; Forrester CA; Ripley PH; Burch DG
    Avian Dis; 1998; 42(4):738-45. PubMed ID: 9876842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two new types of resistance to lincomycin in pathogenic staphylococci from animals.
    Devriese LA
    Ann Microbiol (Paris); 1980; 131B(3):261-6. PubMed ID: 7469255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.